CTRGF yields 2.44% · JNJ yields 2.14%● Live data
📍 CTRGF pulled ahead of the other in Year 1
Combined, CTRGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CTRGF + JNJ for your $10,000?
Country Garden Services Holdings Company Limited, an investment holding company, provides property management services to property owners, residents, and property developers in the People's Republic of China. It offers security, cleaning, green landscaping, gardening, repair and maintenance, and other services. The company's property management portfolio includes residential properties, commercial properties, office buildings, industrial parks, multi-purpose complexes, government buildings, hospitals, and schools, as well as other public facilities, such as airport terminals, highway service stations, scenic areas, and other non-residential properties. As of December 31, 2021, it managed 6,046 property projects. The company also provides community value-added services comprising home, home decoration, community media, value added innovation, real estate brokerage, and community area services. In addition, it offers consultancy services to property developers for the management of their pre-sale activities, as well as consultancy services for properties managed by other property management companies; and cleaning, greening, repair, and maintenance services to property developers at the pre-delivery stage. Further, the company provides sales and leasing agency services of unsold parking spaces and properties; heat supply, city, and city media services; and e-commerce services. The company was founded in 1992 and is headquartered in Foshan, the People's Republic of China.
Full CTRGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.